Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six analysts that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $76.33.
A number of equities research analysts have recently commented on the stock. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and upped their target price for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Truist Financial upped their price objective on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. Bank of America began coverage on National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 target price on the stock. Finally, StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th.
Get Our Latest Analysis on NHI
Institutional Trading of National Health Investors
National Health Investors Trading Down 0.9 %
NYSE:NHI opened at $72.33 on Friday. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors has a 52-week low of $51.59 and a 52-week high of $86.13. The stock’s 50 day moving average price is $77.18 and its 200 day moving average price is $75.32. The company has a market capitalization of $3.29 billion, a PE ratio of 24.85, a P/E/G ratio of 5.05 and a beta of 1.04.
National Health Investors (NYSE:NHI – Get Free Report) last announced its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The business had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business’s revenue was up 1.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.08 earnings per share. On average, research analysts anticipate that National Health Investors will post 4.42 EPS for the current year.
National Health Investors Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 4.98%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is presently 123.71%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More
- Five stocks we like better than National Health Investors
- Technology Stocks Explained: Here’s What to Know About Tech
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- How to Plot Fibonacci Price Inflection Levels
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.